Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study

Finger Paul T.; Chin Kimberly J.; Semenova Ekaterina A.

首页> 外文期刊>European journal of ophthalmology >Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study

【24h】

Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study

机译：玻璃体内抗VEGF治疗黄斑放射性视网膜病变的10年研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To report long-term experience with intravitreal anti-vascular endothelial growth factor treatment for radiation maculopathy.

机译：目的：报告玻璃体腔内抗血管内皮生长因子治疗放射性黄斑病的长期经验。

著录项

来源
《European journal of ophthalmology》 |2016年第1期|共7页
作者
Finger Paul T.; Chin Kimberly J.; Semenova Ekaterina A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
Anti-VEGF; Bevacizumab; Maculopathy; Melanoma; Radiation; Retinopathy;

机译：抗VEGF;贝伐单抗;黄斑病;黑素瘤;放射线;视网膜病;

相似文献

外文文献
中文文献
专利

1. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study [J] . Finger Paul T., Chin Kimberly J., Semenova Ekaterina A. European journal of ophthalmology . 2016,第1期

机译：玻璃体内抗VEGF治疗黄斑放射性视网膜病变的10年研究
2. Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy [J] . Bandello Francesco, Corvi Federico, La Spina Carlo, British journal of ophthalmology . 2016,第12期

机译：玻璃体腔内抗VEGF治疗在新血管性年龄相关性黄斑变性和糖尿病性视网膜病变中的效果
3. OUTCOMES OF INTRAVITREAL ANTI-VEGF THERAPY IN EYES WITH BOTH NEOVASCULAR AGE- RELATED MACULAR DEGENERATION AND DIABETIC RETINOPATHY [J] . Bandello F., Corvi F., Benatti L., European journal of ophthalmology . 2016,第4期

机译：血管内年龄相关性黄斑变性和糖尿病性视网膜病变的眼内抗血管内皮生长因子治疗的结果
4. Deep Learning Based Fully Automated Decision Making for Intravitreal Anti-VEGF Therapy [C] . Simran Barnwal, Vineeta Das, Prabin Kumar Bora International conference on pattern recognition and machine intelligence . 2019

机译：基于深度学习的玻璃体内抗VEGF治疗的全自动决策
5. Arterial Thromboembolic Events following Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy for Age-Related Macular Degeneration in Regular Clinical Practice. [D] . Fafowora, Oluwatoyin Folasade. 2015

机译：在常规临床实践中，玻璃体内血管内皮生长因子抑制剂治疗与年龄相关的黄斑变性的动脉血栓栓塞事件。
6. Pilot study to evaLuate the role of high-dose rAnibizumab 2.0 mg in the management of neovascular age-related macular degeneration in patients with perSistent/recurrenT macular fluid 30 days following treatment with intravitreal anti-VEGF therapy (the LAST Study) [O] . A T Fung, N Kumar, S K Vance, 2012

机译：评价玻璃体腔内抗VEGF治疗后持续/复发黄斑积液30天的患者中大剂量rAnibizumab2.0μmg在新生血管性黄斑变性管理中的作用的初步研究（LAST研究）
7. Pilot study to evaLuate the role of high-dose rAnibizumab 2.0 mg in the management of neovascular age-related macular degeneration in patients with perSistent/recurrenT macular fluid <30 days following treatment with intravitreal anti-VEGF therapy (the LAST Study) [O] . A T Fung, N Kumar, S K Vance, 2012

机译：试点研究评估高剂量ranibizumab 2.0mg在持续/复发性黄斑液患者患者的新血管年龄相关性黄斑运动中的作用<30天后玻璃体抗VEGF治疗（最后一项研究）

Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study

摘要

著录项

相似文献

相关主题

期刊订阅